The Indian health-tech market is expected to grow at a 39 per cent CAGR over FY2020 – FY2023 and is expected to reach $50 billion by 2033, according to RBSA Advisor’s latest report titled “Unleashing the Healthtech Potential”. According to the report, the health technology market currently stands at $2 billion, less than one per cent of the overall healthcare industry.
In India, the health-tech market can be broadly divided into six segments – Telemedicine, e-pharmacy, fitness & wellness, healthcare IT & Analytics, home healthcare and personal health management. Pharm-Easy, Cure fit, Practo are some of the significant health-tech start-ups that have caused a stir and taken the market by storm.
Mr Rajeev shah M&D & CEO of RBSA Advisors, said, “The pandemic and adoption of technology in healthcare has brought a quantum shift in the sector. In recent years, we have seen some of the most significant deals, and the Indian health-tech sector has received close to $1.6 billion in funding since 2017. There is a huge opportunity for growth within health-tech because of the meagre market share in the broader healthcare sector. The most crucial factors driving the growth currently are Covid-induced restrictions and safety protocols, and the acceptance of technology in the industry. As the industry is looking to grow at a phenomenal rate, the investors are ready to invest in this sunshine sector”.
